案例报告
Neoadjuvant and Adjuvant Crizotinib Targeted Therapy in Stage Iiia-N2 Alk-Positive NonSmall-Cell Lung Cance
English 
Spanish 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi